On November 12, 2020, ALTEOGEN Inc. (KOSDAQ:A196170) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
284,500 KRW | -0.52% | +9.63% | +188.83% |
2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+188.83% | 10.9B | |
+2.99% | 94.76B | |
-3.68% | 37.58B | |
-9.65% | 33.3B | |
+75.41% | 27.92B | |
-13.68% | 15.85B | |
-3.74% | 13.79B | |
-12.31% | 11.51B | |
-53.94% | 9.27B | |
+5.84% | 9.09B |
- Stock Market
- Equities
- A196170 Stock
- News ALTEOGEN Inc.
- ALTEOGEN Inc. announced that it has received KRW 29.9992875 billion in funding from Shinhan Bank, SL Investment, Future Growth Strategy Bio New Technology Investment Fund, Korea Investment Holdings Co., Ltd., Korea Securities Finance Corporation